Audacious Goals Initiative High Priority Research Area: Intersection of Aging and Biological Mechanisms of Eye Disease (R01)

The summary for the Audacious Goals Initiative High Priority Research Area: Intersection of Aging and Biological Mechanisms of Eye Disease (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Audacious Goals Initiative High Priority Research Area: Intersection of Aging and Biological Mechanisms of Eye Disease (R01): The purpose of this Funding Opportunity Announcement (FOA) for the National Eye Institute (NEI) is to encourage submission of new, innovative projects directed to exploring this area through: 1) understanding how the biology of aging contributes to disease; 2) evaluating how the failure of homeostatic processes causes or allows the transition from aging to early disease; 3) defining the biological staging of disease to understand pathophysiology, identify biomarkers, and explore therapy; and 4) distinguishing normal ocular changes associated with aging from pathophysiologic changes. Advanced age is a risk factor for many of the leading causes of vision loss, including age-related macular degeneration, cataract, glaucoma, diabetic retinopathy, dry eye syndrome, and presbyopia. Better knowledge of the biological mechanisms of disease will lead to new strategies to prevent or delay progress of these age-related blinding conditions. An application may propose design-directed, developmental, discovery-driven, or hypothesis-driven research. It is appropriate to propose small, multidisciplinary teams applying an integrative approach to solve these problems.

Federal Grant Title:	Audacious Goals Initiative High Priority Research Area: Intersection of Aging and Biological Mechanisms of Eye Disease (R01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PA-13-332
Type of Funding:	Grant
CFDA Numbers:	93.866
CFDA Descriptions:	Aging Research
Current Application Deadline:	Jan 07, 2017
Original Application Deadline:	Jan 07, 2017
Posted Date:	Aug 13, 2013
Creation Date:	Aug 13, 2013
Archive Date:	Feb 07, 2017
Total Program Funding:
Maximum Federal Grant Award:	none
Minimum Federal Grant Award:	none
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Native American tribal governments (Federally recognized)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
For profit organizations other than small businesses
State governments
City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
Independent school districts
Public and State controlled institutions of higher education
Small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Special district governments
Private institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/PA-13-332.html
Grant Announcement Contact: NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants: • Coordinating Center to Support Consortium for Neuroscience Alzheimers Disease (AD) and AD-...; • Small Research Grant Program for the Next Generation of Researchers in Low- and Middle-Inc...; • Consortium for Neuroscience AD/ADRD in Low- and Middle-Income Countries (U01 Clinical Tri...; • NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational R...; • Short Courses Promoting Cross-National Analyses Using Data from the International Health a...; • Technological Enhancements and Archiving for Surveys of the Elderly: SBIR (R43/44) Initiat...; • Technological Enhancements and Archiving for Surveys of the Elderly: STTR (R41/42) Initiat...; • Technology and Aging: NIA Small Business Technology Transfer Program Initiative (STTR [R41...
More Grants from the National Institutes of Health: • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...; • Cellular Models of HIV Pathogenesis within NIDDK Mission Areas (R01 Clinical Trial Not All...; • U.S.-South Africa Program for Collaborative Biomedical Research Phase 3 (HIV/AIDS) (R01 C...; • Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Option...; • Research Centers in Minority Institutions (RCMI) (U54 - Clinical Trial Optional)